In the present study, we employed BRD3308, a new selective inhibitor of HDAC3, for early intervention in septic mice, observed its potential alleviating effect on ALI, and investigated the associated mechanisms, aiming to provide novel strategies for clinically preventing and treating sepsis-induced ALI. Here, HDAC3 is linked to Sepsis.